The Journal of Toxicological Sciences
Online ISSN : 1880-3989
Print ISSN : 0388-1350
ISSN-L : 0388-1350
Regular Paper
CHARACTERISTICS OF THE HEMOSTATIC ACTION OF KFA-1411, AN INHIBITOR OF COAGULATION FACTOR Xa (FXa), IN HUMANS AND VARIOUS ANIMALS
Kiyoto HARAToshiki HONMAAkane MATSUZAWAAtsushi MATSUZAWAMasahiko UCHIDATakashi KOIZUMISatoshi AKAHANEMasami KOJIMA
Author information
JOURNALS FREE ACCESS

2003 Volume 28 Issue 1 Pages 25-34

Details
Abstract

This study examined a low-molecular-weight factor-Xa inhibitor, KFA-1411 (3-[N-(3-amidinophenyl)-N-[N-[4-[1-(1-iminoethyl)piperidin-4-yl]phenyl]carbamoylmethyl]aminomethyl]phenoxyacetic acid monosulfonate·dihydrate). KFA-1411 selectively inhibited FXa among the serine proteases in the human blood-coagulation cascade with a Ki value of 1.73 nM, (selectivity ratio, 15000 versus its action on thrombin). The anticoagulant action of KFA-1411 in human plasma almost equaled that of the selective thrombin inhibitor, argatroban. KFA-1411 did not inhibit platelet aggregation at the concentration at which it showed an anticoagulant action. In contrast, argatroban, heparin, and low-molecular-weight heparin (LMWH; dalteparin) inhibited thrombin-induced platelet aggregation at concentrations lower than those needed for their anticoagulant actions. The FXa-inhibiting action of KFA-1411 differed among animal species, the maximum effect being seen in humans, followed by monkeys and rabbits, with rats and mice showing about one-tenth the potency seen in humans. A species variation was also observed among the values obtained for KFA-1411 in respect of anticoagulant activity in plasma (monkeys again being closest to humans).
These results indicate that KFA-1411 may exhibit antithrombotic efficacy without an unwanted platelet-related action in the future treatment of various thrombotic diseases. The experimental model of monkeys is recommended for estimation of the clinical effects and safety of KFA-1411 in humans.

Information related to the author
© 2003 The Japanese Society of Toxicology
Previous article Next article
feedback
Top